Latest Developments in Global Cystoisopora Infection Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Cystoisopora Infection Market

  • Pharmaceutical
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In January 2024, IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the expansion of its Fecal Dx antigen testing platform to include Cystoisospora, a common intestinal parasite that causes diarrhea, weight loss, and dehydration, particularly in young dogs and cats. IDEXX's Fecal Dx antigen testing provides earlier and more accurate detection of the most prevalent and clinically significant intestinal parasites in dogs and cats, including hookworms, roundworms, whipworms, flea tapeworms, and now Cystoisospora. The new Fecal Dx antigen test for Cystoisospora is scheduled for launch in North America in March and will be available globally in Q3 2024 through IDEXX Reference Laboratories